Metropolis Healthcare Bonus Record Date on March 20: Declared 3:1 Bonus Issue

Metropolis Healthcare Ltd has set March 20, 2026, as the record date for its 3:1 bonus. This means that every eligible shareholder will be receiving 3 free shares for every 1 share held. 

Metropolis Healthcare Ltd said in an exchange filing, “The Board of Directors of the Company and subsequent approval of the shareholders (via Postal Ballot) of the Company, for the issuance of Bonus Equity Shares in the ratio of 3:1, i.e., Three (3) new fully paid-up Equity Shares of face value of INR 2/- (Indian Rupees Two only) each for every One (1) existing fully paid-up Equity Share of face value of INR 2/- (Indian Rupees Two only) each.” 

What Does Metropolis Healthcare Bonus Record Date Mean for Shareholders?

As Metropolis Healthcare has set March 20, 2026, as the record date for the bonus issue, meaning that March 19 is the last day to buy Metropolis Healthcare shares to become eligible for the bonus issue. Further, any shares bought on or after March 20 (record date) won't be eligible for the bonus shares due to the T+1 settlement rule.

Also Read: REC Dividend Record Date on March 20: Interim Dividend of ₹4.60

Metropolis Healthcare Management Take on Q3FY26 Earnings

Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Limited, said, “The diagnostics sector in India is at a pivotal inflexion point, driven by the growing adoption of preventive healthcare, a rising chronic disease burden, and the expansion of organised healthcare across Tier II and Tier III markets. Our Q3 performance reflects how Metropolis is capturing these opportunities through a clear strategic focus and sustained investments in specialised capabilities. As our genomics and advanced diagnostics platforms scale, we are building a science-led, resilient, and future-ready diagnostics institution that meaningfully advances clinical decision-making and delivers enduring value for patients, clinicians, and the wider healthcare ecosystem.”

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.